Rajesh Exports, Tata Motors PV, Auro Pharma, ICICI Bank and more: Stocks to Watch for June 5

Rajesh Exports, Tata Motors PV, Auro Pharma, ICICI Bank and more: Stocks to Watch for June 5


Rajesh Exports defends disclosures after SEBI concerns, Tata Motors targets over 20% PV share by 2030, ICICI Bank gets SEBI warning, Aurobindo wins US FDA nod, CG Power starts new EHV unit. Here are few stocks to track ahead of Friday’s trading session.

By Megha Rani  June 4, 2026, 8:18:54 PM IST (Updated)

2 Min Read

Rajesh Exports share price

Image count1 / 5

Rajesh Exports | The firm’s Chairman Rajesh Mehta told Reuters that the company’s financial disclosures were accurate and that SEBI’s concerns stemmed from differences in revenue calculations that did not account for consolidated revenue. His remarks came a day after the regulator alleged that 97–99% of the jeweller’s revenue came from overseas subsidiaries, mainly Valcambi SA, whose financials were not disclosed.

Tata Motors, Tata Motors PV share price

Image count2 / 5

Tata Motors Passenger Vehicles | Chairman N Chandrasekaran said the company should target a market share of over 20% by 2030 if India’s passenger vehicle market reaches 6 million units. Speaking at the company’s dealer business planning meet in Goa, he reaffirmed Tata Motors’ ₹35,000 crore investment commitment through 2030 and said the plan could be recalibrated as needed, while highlighting the company’s rise from calls to exit the passenger vehicle business in 2017 to becoming one of the country’s top two automakers.

Image count3 / 5

ICICI Bank | The bank said it has received a warning letter from SEBI regarding its role as a custodian, after allowing a foreign portfolio investor (FPI) to repatriate funds before completing the mandatory retention period under the voluntary retention route (VRR). The regulator cited violations of RBI directions and SEBI’s FPI regulations.

Aurobindo Pharma share price, Aurobindo Pharma stock

Image count4 / 5

Aurobindo Pharma | Pharma major said it has received final US FDA approval for its tofacitinib tablets in 5 mg and 10 mg strengths, a generic version of Xeljanz. The drug, used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis in adults, will be manufactured at its subsidiary APL Healthcare Unit IV and launched immediately in the US market.

CG Power and Industrial Solutions share price, CG Power share price

Image count5 / 5

CG Power and Industrial Solutions | The company has commenced commercial production at its new extra high-voltage (EHV) switchgear manufacturing facility, S3 Unit-II, in Nashik, Maharashtra. The plant is part of the company’s ₹748.2 crore greenfield switchgear expansion plan and complements its existing S3 Unit-I facility, which manufactures EHV circuit breakers in the 33kV–800kV range.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *